Bcl-2 Correlates with Tumor Ploidy and Nuclear Morphology in Early Stage Prostate Carcinoma. A Fine Needle Aspiration Biopsy Study

Amling, 1999, Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer, J Urol, 161, 857, 10.1016/S0022-5347(01)61790-7 Andersson, 1994, Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer, Scand J Urol Nephrol Suppl, 162, 43 Baretton, 1994, Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: An image cytometric study, Hum Pathol, 25, 506, 10.1016/0046-8177(94)90123-6 Bubendorf, 1996, Prognostic significance of bcl-2 in clinically localized prostate cancer, Amer J Path, 148, 1557 Chiusa, 1997, High and low risk prostate carcinoma determined by histologic grade and proliferative activity, Cancer, 79, 1956, 10.1002/(SICI)1097-0142(19970515)79:10<1956::AID-CNCR17>3.0.CO;2-U Eble, 1992, The roles of fine needle aspiration and needle core biopsies in diagnosis of primary prostatic cancer, Hum Pathol, 23, 249, 10.1016/0046-8177(92)90105-C Epstein, 1996, The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens, Cancer, 78, 350, 10.1002/(SICI)1097-0142(19960715)78:2<350::AID-CNCR26>3.0.CO;2-U Epstein, 1992, Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy, J Urol, 148, 87, 10.1016/S0022-5347(17)36518-7 Forsslund, 1996, Near tetraploid prostate carcinoma. Methodologic and prognostic aspects, Cancer, 78, 1748, 10.1002/(SICI)1097-0142(19961015)78:8<1748::AID-CNCR15>3.0.CO;2-Y Forsslund, 1990, Ploidy levels determinations in high-grade and low-grade malignant variants of prostatic carcinoma, Cancer Res, 50, 4281 Gschwendtner, 1997, Ploidy determination on histologic sections of breast cancer specimens by image analysis using mathematical correction algorithms, Mod Pathol, 10, 751 Johnson, 1998, Expression of bcl-2, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation, Prostate, 37, 223, 10.1002/(SICI)1097-0045(19981201)37:4<223::AID-PROS3>3.0.CO;2-O Kass, 2000, Detection of bromodeoxyuridine in formalinfixed tissue. DNA denaturation following microwave or enzymatic digestion pretreatment is required, Eur J Histotechnol, 44, 185 Korsmeyer, 1992, Bcl-2 initiates a new category of oncogenes: regulators of cell death, Blood, 80, 879, 10.1182/blood.V80.4.879.879 Lipponen, 1997, Expression of the apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy, Prostate, 32, 9, 10.1002/(SICI)1097-0045(19970615)32:1<9::AID-PROS2>3.0.CO;2-I Mostofi, 1992, Pathology of carcinoma of the prostate, Cancer, 70, 235, 10.1002/1097-0142(19920701)70:1+<235::AID-CNCR2820701311>3.0.CO;2-G Moul, 1996, Protein expression of p53, bcl-2 and Ki-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer, Surgery, 120, 159, 10.1016/S0039-6060(96)80283-2 Muñoz de Toro, 1995, Effect of microwave pretreatment on proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections, J Histotechnol, 18, 11, 10.1179/his.1995.18.1.11 Muñoz de Toro, 1998, Proliferative activity and steroid hormone receptor status in male breast carcinoma, J Steroid Biochem Molec Biol, 67, 1 Muñoz de Toro, 1998, Processing fine needle aspirates of prostate carcinoma for standard immunocytochemical studies and in situ apoptosis detection, Pathol Res Pract, 194, 631, 10.1016/S0344-0338(98)80098-8 Rudin, 1997, Apoptosis and Disease: Regulation and clinical relevance of programmed cell death, Annu Rev Med, 48, 267, 10.1146/annurev.med.48.1.267 Siegel, 1956, Nonparametric Statistics for the Behavioral Sciences, 121 Stattin, 1998, Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer, Br J Cancer, 77, 670, 10.1038/bjc.1998.107 Trerè, 1996, AgNOR quantity in needle biopsy specimens of prostatic adenocarcinomas: correlation with proliferation state, Gleason score, clinical stage, and DNA content, J Clin Pathol Mol Pathol, 49, 209, 10.1136/mp.49.4.M209 Tu, 1996, Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-b1 and bcl-2 expression, Int J Cancer (Pred Oncol), 69, 357, 10.1002/(SICI)1097-0215(19961021)69:5<357::AID-IJC1>3.0.CO;2-4 van der Poel, 1992, Quantitative light microscopy in urological oncology, J Urol, 148, 1, 10.1016/S0022-5347(17)36494-7